In alignment with World Sight Day 2024's theme “Children, Love Your Eyes,” RetinaLyze has announced the launch of its Advanced Glaucoma Progression AI.
Central to this innovation is the Glaucoma Index of Progression (GIP), a tool designed to offer a stable and consistent method for tracking glaucoma over time. This advancement provides crucial insights for eye care professionals, even when patient measurements fall within normal ranges.
A new tool for early detection and monitoring
Glaucoma is often referred to as the "silent thief of sight" due to its gradual progression without noticeable symptoms until significant vision loss occurs.
Early detection and regular monitoring are vital for preventing irreversible damage. RetinaLyze's Advanced Glaucoma addresses this need by measuring changes in glaucoma status with notable stability.
Why RetinaLyze Advanced Glaucoma is needed
To illustrate the importance of monitoring changes within normal ranges, consider the analogy of height measurement. An individual who was 1.80 meters tall a year ago and is now 1.70 meters tall is still within the normal height range.
However, the decrease indicates a potential underlying issue that warrants attention. Similarly, a patient's glaucoma condition can worsen even if their measurements remain within statistically normal ranges. Advanced Glaucoma helps clinicians detect these subtle changes early.
Simultaneous evaluation of both eyes
The Advanced Glaucoma Progression AI also features the ability to compare changes in both eyes simultaneously.
By analyzing and displaying results side by side, eye care professionals can examine GIP indices along with the estimated areas of the optic cup and rim sectors.
This comprehensive overview facilitates a better understanding of the progression or regression affecting the optic nerve and surrounding structures.
Empowering eye care professionals
RetinaLyze's commitment to supporting optometrists, ophthalmologists, and other eye care professionals is evident in this latest offering.
The tool simplifies the process of providing in-depth eye screenings, making advanced glaucoma monitoring more accessible and efficient.
Join the movement on World Sight Day
As the world focuses on eye health, particularly for children, RetinaLyze emphasizes that protecting vision is a life long commitment. Regular check-ups and advanced tools like the Advanced Glaucoma are essential for maintaining eye health for all ages.
Eye care professionals interested in incorporating the RetinaLyze Advanced Glaucoma Progression AI into their practice can start with a free trial.
🔗 Signup for the free trial: https://www.retinalyze.com/try